S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
Abstract Motivational deficits (e.g., apathy) and dysregulation (e.g., addiction) in HIV-1 seropositive individuals, despite treatment with combination antiretroviral therapy, necessitates the development of innovative adjunctive therapeutics. S-Equol (SE), a selective estrogen receptor β agonist, h...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e54c76ad5c684d5f8c80d1bf6cbe203a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|